source
- US ‘eroding’ lead in rare diseases a matter of national security: ReportA Congressional advisory panel recommends the U.S. government put supportive policies in place for rare disease drug development, such as a finalized platform designation from the FDA and the allow…BioSpace · 9d ago↗ source
- Crystalys nets $130M more to push gout drug through late-stage testsThe startup has a broad global development program underway — and the support of more than 20 investment firms — for a treatment that’s approved in many Asian countries but isn’t yet available in t…BioPharma Dive · 9d ago↗ source
- Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsWhat Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more health news